1. Köttgen A, Hwang SJ, Larson MG, Van Eyk JE, Fu Q, Benjamin EJ, Dehghan A, Glazer NL, Kao WHL, Harris TB, Gudnason V, Shlipak MG, Yang Q, Coresh J, Levy D, Fox CS. Uromodulin Levels are Associated with Common Variation in the UMOD Gene and Risk of Incident Chronic Kidney Disease. J Am Soc Nephrol. 2009, Dec 3. [Epub ahead of print]
2. Ganesh SK, Zakai NA, van Rooij FJ, Soranzo N, Smith AV, Nalls MA, Chen MH, Kottgen A, Glazer NL, Dehghan A, Kuhnel B, Aspelund T, Yang Q, Tanaka T, Jaffe A, Bis JC, Verwoert GC, Teumer A, Fox CS, Guralnik JM, Ehret GB, Rice K, Felix JF, Rendon A, Eiriksdottir G, Levy D, Patel KV, Boerwinkle E, Rotter JI, Hofman A, Sambrook JG, Hernandez DG, Zheng G, Bandinelli S, Singleton AB, Coresh J, Lumley T, Uitterlinden AG, Vangils JM, Launer LJ, Cupples LA, Oostra BA, Zwaginga JJ, Ouwehand WH, Thein SL, Meisinger C, Deloukas P, Nauck M, Spector TD, Gieger C, Gudnason V, van Duijn CM, Psaty BM, Ferrucci L, Chakravarti A, Greinacher A, O'Donnell CJ, Witteman JC, Furth S, Cushman M, Harris TB, Lin JP. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet. 2009 Nov;41(11):1191-8.
3. Benjamin EJ, Rice KM, Arking DE, Pfeufer A, van Noord C, Smith AV, Schnabel RB, Bis JC, Boerwinkle E, Sinner MF, Dehghan A, Lubitz SA, D’Agostino Sr, RB, Lumley T, Ehret GB, Heeringa J, Aspelund T, Newton-Cheh C, Larson MG, Marciante KD, Soliman EZ, Rivadeneira F, Wang TJ, Eiríksdóttir G, Levy D, Psaty BM, Li M, Chamberlain AM, Hofman A, Vasan RS, Harris TB, Rotter JI, Kao WHL, Agarwal SK, Stricker BH, Wang K, Launer LJ, Smith NL, Chakravarti A, Uitterlinden AG, Wolf PA, Sotoodehnia A, Köttgen A, van Duijn CM, Meitinger T, Mueller M, Perz S, Steinbeck G, Wichmann HE, Lunetta KL, Heckbert SR, Gudnason V, Alonso A, Kääb S, Ellinor PT, Witteman JC. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet. 2009 Aug;41(8):879-81.
4. Bash LD, Coresh J, Köttgen A, Parekh R, Fulop T, Wang Y, Astor BC. Definition of Incident Chronic Kidney Disease in the Research Setting: The ARIC Study. Am J Epidemiol, 2009 Aug 15;170(4):414-24.
5. Woodward OM*, Köttgen A*, Coresh J, Boerwinkle E, Guggino WB, Köttgen M. Identification of a novel urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10338-42.
6. Selvin E, Köttgen A, Coresh J. Kidney Function Estimated from Serum Creatinine and Cystatin C and Peripheral Arterial Disease in NHANES 1999-2002. Eur J Heart, 2009 Aug;30(15):1918-25.
7. Köttgen A*, Glazer NL*, Dehghan A*, Hwang SJ*, Katz R, Li M, Yang Q, Gudnason V, Launer LJ, Harris TB, Smith AV, Arking DE, Astor BC, Boerwinkle E, Ehret GB, Ruczinski I, Scharpf RB, Chen YI, de Boer IH, Haritunians T, Lumley T, Sarnak M, Siscovick D, Benjamin EJ, Levy D, Upadhyay A, Aulchenko YS, Hofman A, Rivadeneira F, Uitterlinden AG, van Duijn CM, Chasman DI, Paré G, Ridker PM, Kao WHL, Witteman JC, Coresh J, Shlipak MG, Fox CS. Multiple Novel Loci are Associated with Indices of Renal Function and Chronic Kidney Disease. Nat Genet, 2009 Jun;41(6):712-717.
8. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, Glazer NL, Morrison AC, Johnson AD, Aspelund T, Aulchenko Y, Lumley T, Köttgen A, Vasan RS, Rivadeneira F, Eiriksdottir G, Guo X, Arking DE, Mitchell GF, Mattace-Raso FUS, Smith AV, Taylor K, Scharpf RB, Hwang SJ, Sijbrands EJG, Bis J, Harris TB, Ganesh SK, O’Donnell CJ, Hofman A, Rotter JI, Coresh J, Benjamin EJ, Uitterlinden AG, Heiss G, Fox CS, Witteman JCM, Boerwinkle E, Wang TJ, Gudnason V, Larson MG, Chakravarti A, Psaty BM, van Duijn CM (2009). Association of Common Genetic Variants with Blood Pressure and Hypertension: A Genome-Wide Association Study of Six Population-based Cohort Studies, Replication, and Meta-analysis. Nat Genet, 2009 Jun;41(6):677-687.
9. Pfeufer A, Sanna S, Arking DE, Müller M, Gateva V, Fuchsberger C, Ehret GB, Orrú M, Pattaro C, Köttgen A, Perz S, Usala G, Barbalic M, Li M, Pütz B, Scuteri A, Prineas RJ, Sinner MF, Gieger C, Najjar SS, Kao WH, Mühleisen TW, Dei M, Happle C, Möhlenkamp S, Crisponi L, Erbel R, Jöckel KH, Naitza S, Steinbeck G, Marroni F, Hicks AA, Lakatta E, Müller-Myhsok B, Pramstaller PP, Wichmann HE, Schlessinger D, Boerwinkle E, Meitinger T, Uda M, Coresh J, Kääb S, Abecasis GR, Chakravarti A. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet. 2009 Apr;41(4):407-14.
10. Dehghan A*, Köttgen A*, Yang Q*, Hwang SJ, Kao WHL, Uitterlinden AG, Boerwinkle E, Levy D, Hofman A, Astor BC, Benjamin EJ, van Duijn CM, Witteman JC*, Coresh J*, Fox CS*. Association of Three Genetic Loci with Uric Acid Levels and Gout Risk. Lancet. 2008 Dec 6;372(9654):1953-61.
11. Pazin Filho A, Köttgen A, Bertoni AG, Russell SD, Selvin E, Rosamond WD, Coresh J. Hemoglobin A1c as a Risk Factor for Heart Failure in Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetologia. 2008 Dec;51(12):2197-204.
12. Köttgen A, Hsu CC, Coresh J, Shuldiner AR, Berthier-Schaad Y, Gambhir TR, Smith MW, Boerwinkle E, Kao WH. The association of podocin R229Q polymorphism with increased albuminuria or reduced estimated GFR in a large population-based sample of U.S. adults. Am J Kidney Dis. 2008 Nov;52(5):868-875.
13. Groesbeck D, Köttgen A, Selvin E, Coresh J, Furth SL. Reference Ranges and Sources of Variation for Cystatin C in the Adolescent Population of the National Health and Nutrition Examination Survey (NHANES) III. Clin J Am Soc Nephrol. 2008 Nov;3(6):1777-85.
14. Köttgen A, Hwang S, Rampersaud E, Coresh J, North KE, Pankow JS, Meigs JB, Florez JC, Levy D, Boerwinkle E, Shuldiner AR, Fox CS, Kao WH. TCF7L2 Variants Associate with CKD Progression and Renal Function in Population-based Cohorts. J Am Soc Nephrol. 2008 Oct;19(10):1989-99.
15. Yan Y, North KE, Ballantyne CM, Brancati FL, Franceschini N, Heiss G, Köttgen A, Pankow JS, Selvin E, West SL, Boerwinkle E. Transcription Factor 7-Like 2 (TCF7L2) Polymorphism and Context Specific Lifetime Risk of Type 2 Diabetes in African American and Caucasian Adults: The Atherosclerosis Risk in Communities Study. Diabetes. 2009 Jan;58(1):285-9.
16. Köttgen A, Kao WH, Hwang SH, Boerwinkle E, Yang Q, Levy D, Benjamin EJ, Larson M, Astor BC, Coresh J & Fox CS. Genome-Wide Association Study for Renal Traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies. BMC Med Genet. 2008 Jun 3;9:49.
17. Köttgen A, Selvin E, Stevens LA, Levey AS, Van Lente F, Coresh J. Serum Cystatin C in the U.S.: the Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2008 51:385-394.
18. Köttgen A, Russell S, Loehr L, Crainiceanu C, Rosamond W, Chang P, Chambless L, Coresh, J. Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol. 2007 Apr;18(4): 1307-15.
19. Waldegger S, Fakler B, Bleich M, Barth P, Hopf A, Schulte U, Busch AE, Aller SG, Forrest J, Greger R, Lang F. Molecular and functional characterization of sKCNQ1 potassium channel from rectal gland of Squalus acanthias. Pflugers Arch. 1999 Jan;437(2):298-304.
20. Schreiber R, Hopf A, Mall M, Greger R, Kunzelmann K. The first nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator is required for inhibition of the epithelial Na+ channel. Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5310-5
21. Hopf A, Schreiber R, Mall M, Greger R, Kunzelmann K. CFTR inhibits the activity of epithelial Na+ channels carrying Liddle's syndrome mutations. J Biol Chem. 1999 May 14;274(20):13894-9.
